SCHEMBL9535888

SCHEMBL9535888

COc1ccc(Cc2ccnc(N)c2N)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
CYP2D6 P10635 1/20 0.51
ATM Q13315 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
POLB P06746 1/20 0.48
MPO P05164 1/20 0.47
LMNA P02545 2/20 0.45
HPGD P15428 1/20 0.45
LTA4H P09960 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
PDE10A Q9Y233 1/20 0.43
ROCK1 Q13464 1/20 0.43
IDO1 P14902 1/20 0.43
CSF1R P07333 2/20 0.42
NTRK2 Q16620 2/20 0.42
NTRK1 P04629 1/20 0.42
NTRK3 Q16288 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28362008 0.86 ALDH1A1 (0.50) ALDH1A1CYP2D6ATMNPC1RAB9A
SCHEMBL23045757 0.86 ALDH1A1 (0.58) ALDH1A1CYP2D6ATMNPC1RAB9A
Ammonia Solution, Strong SCHEMBL2450875 0.84 ALDH1A1 (0.53) ALDH1A1CYP2D6ATMNPC1RAB9A
Ammonia Solution, Strong SCHEMBL25279198 0.84 ALDH1A1 (0.56) ALDH1A1CYP2D6ATMNPC1RAB9A
SCHEMBL28334222 0.83 CSF1R (0.67) NPC1RAB9ACSF1RNTRK2NTRK1
SCHEMBL30368088 0.83 CSF1R (0.67) NPC1RAB9ACSF1RNTRK2NTRK1
SCHEMBL9536189 0.81 NOS2 (0.47) ALDH1A1NPC1RAB9ALTA4HSMN1; SMN2
SCHEMBL9391619 0.81 NPC1 (0.61) ALDH1A1CYP2D6ATMNPC1RAB9A
SCHEMBL7000300 0.80 KCNH2 (0.42) ALDH1A1MPODHFR
SCHEMBL31279567 0.80 MPO (0.47) ALDH1A1CYP2D6ATMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117946138-A And ring nitrogen-containing compound, intermediate thereof, preparation method and application 杭州圣域生物医药科技有限公司 2024-04-30 CN disclosed
EP-0151826-B1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-31 EP disclosed
EP-0151826-A1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1985-08-21 EP disclosed